Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Sileon in connection with its rights issue
Mandate

Vinge has advised Sileon in connection with its rights issue

October 23, 2023 M&A

Vinge has advised Sileon AB (publ) in connection with its rights issue, which provides the company with proceeds of approximately SEK 33.8 million before deduction of transaction costs.

The rights issue is primarily intended to finance ongoing commercialization activities, product development, and general working capital. Sileon is a global fintech company that offers an innovative card-based Buy Now Pay Later (BNPL) SaaS functionality to banks, card issuers and fintechs. Sileon is listed on Nasdaq First North Growth Market.

Vinge’s team consisted of Anders Strid, Edin Agic och Adrian Filipovic.

  

Related

Vinge advises HealthCap in conjunction with an investment in Neobiomics

 HealthCap is investing in Neobiomics AB, which develops products in the neonatal field. Neobiomics’ flagship product, Proprems, is a probiotic dietary supplement developed for preterm infants.
May 22, 2026

Vinge advises Sveafastigheter in its merger with KlaraBo

 Vinge advises Sveafastigheter AB (publ) in its merger with KlaraBo Sverige AB.
May 22, 2026

Vinge advises Lagercrantz Group in conjunction with the acquisition of Stalon

 Lagercrantz Group Aktiebolag has acquired 88 per cent of the shares in Stalon AB, a Swedish manufacturer of silencers for hunting firearms. The company is based in Stalon, which is located outside Vilhelmina, where the company conducts development and production in its own facilities.
May 21, 2026